CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1999; 49:74
doi: 10.3322/canjclin.49.2.74
© 1999 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lum, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lum, L. G.

CA: A Cancer Journal for Clinicians, Vol 49, Issue 2 74-100, Copyright © 1999 by American Cancer Society

ARTICLES

T cell-based immunotherapy for cancer: a virtual reality?

L. G. Lum
Immunotherapy and Autologous Bone Marrow Transplant Programs, Immunotherapy Research and Treatment Institute, St. Luke's Medical Center, Milwaukee, WI, USA.

The goal of harnessing the immune system to recognize tumor as "nonself" is not new. Now, thanks to new knowledge and new techniques, however, modalities that seek to activate the host immune system are becoming increasingly feasible as treatments for advanced malignancies.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by American Cancer Society.